Karande Anjali Vijay

Career objective

To leverage my academic knowledge and skills in a professional setting, contributing to the growth and success of an organization. To develop expertise in my chosen field while gaining hands-on experience and enhancing my abilities. To work in a dynamic and challenging environment where i can make meaningful contributions and grow as a professional. To continually learn and contribute to the advancement of both my career and society.

• Regulatory Affairs

• Research and Development

• Biologics and Biosimilars

• Quality Assurance

• Clinical Data Management

• Quality Control

 • Cross- Functional Collaboration 

 • Networking and Relationship Building 

 • Time Management 

 • Team Work 

 • Leadership skills

 • Adaptability

• National Conference on Next-generation therapeutics and delivery systems, NIPER-R
• Short-term departmental training on an advanced technique, 1 month
• Training Programme in Animal Handling and Drug Administration, NIPER-R
• National Service Scheme Programme, As a volunteer conducted by Government of India, Ministry of Youth Affairs and Sports

Postgraduate Research Scholar, Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER-Raebareli), Lucknow, UP, 226002

• MHT-CET 2019 QUALIFIED
• GPAT 2023 Qualified (AIR 880)
• NIPER JEE 2023 Qualified (AIR1213)

Actively participating in departmental activities

Won cricket at NIPER-R

Won tug of war at NIPER-R

As a NSS Volunteer conducted by the Govt. of India Ministry of Youth Affairs and Sports

My research focuses on plant-derived extracellular vesicles (PDNVs) in diabetic wound healing emphasize their potential as innovative therapeutic agents to enhance tissue repair and regeneration. PDNVs are rich in bioactive molecules, including proteins and miRNAs, that can modulate cellular processes critical for wound healing, such as angiogenesis, inflammation, and cellular proliferation. For instance, studies have shown that PDNVs can significantly improve fibroblast migration and collagen deposition, crucial for re-epithelialization and tissue integrity. Additionally, when incorporated into biocompatible hydrogels, PDNVs facilitate controlled release and sustained therapeutic effects, effectively addressing the complex pathogenesis of diabetic wounds. This approach not only enhances healing outcomes but also reduces the risk of infection by modulating the wound microenvironment. Overall, the integration of PDNVs into wound care strategies presents a promising avenue for improving clinical outcomes in patients with chronic diabetic wounds.

I hereby declare that the details stated above are true and correct to the best of my knowledge.